References
- Cronberg S, Banke S, Bruno A-M, Carlsson M, Elmrud H, Elowsson S, et al. Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis. Scand J Infect Dis 1995; 27: 463–8.
- Sandberg T, Englund G, Lincoln K, Nilsson L-G. Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis 1990; 9: 317–23.
- Olsson-Liljequist B, Gezelius L, Dennford J, Jörbeck H, Jönsson B, Lundbäck A, et al. Ceftibuten (Cedax) in a Swedish multicenter study: High activity against gram-negative pathogens. First European Congress of Chemotherapy, 14–17 May 1996, Glasgow, UK.
- Banfi A, Gabriele G, Hill-Juarez JM, Kaufman A, Moens E. for the Ceftibuten Urinary Tract Infection International Study Group. Multinational comparative trial of ceftibuten and trimethoprim-sulfamethoxazole in the treatment of childrenwith complicated or recurrent urinary tract infections. Pediatr Infect Dis J 1990; 12: 884–91.
- Swedish Urinary Tract Infection Study Group. Interpretation of the bacteriologic outcome of antibiotic treatment for uncomplicated cystitis: impact of the definition of significant bacteriuria in a comparison of ritipenem axocil with norfloxacin. Clin Infect Dis 1995; 20: 507–13.
- Cars O, Craig WA. Pharmacodynamics of antibiotics—consquences for dosing. Scand J Infect Dis 1991; Suppl 74: 282–3.
- Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745–58.
- Ode B, Bröms M, Walder M, Cronberg S. Failure of excessive doses of ampicillin to prevent bacterial relapse in the treatment of acute pyelonephritis. Acta Med Scand 1980; 207: 305–7.
- Jernelius H, Zbornik J, Bauer CA. One or three weeks’ treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin and pivmecillinam. Acta Med Scand 1988; 223: 469–77.